The Association betweenLRRK2G2385R and Phenotype of Parkinson’s Disease in Asian Population: A Meta-Analysis of Comparative Studies
Authors:
Open Access
- 10 July 2018
- journal article
- research article
- Published by Wiley in Parkinson's Disease
- Vol. 2018, 1-7
Abstract
Numerous studies have investigated the relationship between theLRRK2G2385R variant and clinical characteristics in Parkinson’s disease (PD), but the results have been inconsistent. This study investigated whether theLRRK2G2385R variant was associated with a unique clinical phenotype of PD in the Asian population, using a meta-analysis. The PubMed, Web of Science, EMBASE, CNKI, and WANFANG databases were searched until September 2017. The strict selection criteria and exclusion criteria were determined, and mean differences (MD) or odds ratios (OR) with 95% confidence intervals (CI) were used to assess the strength of associations. Statistical analyses and graphics were performed using Review Manager 5.3. Sixteen related case-control studies were included in the meta-analysis. TheLRRK2G2385R carriers significantly more often presented a family history (OR: 1.98; 95% CI: 1.16−3.39;) and had a longer disease duration (MD = 0.47, 95% CI: 0.01−0.93,) and a higher MMSE score (MD = 1.02, 95% CI: 0.43–1.62) thanLRRK2G2385R noncarriers. There were no significant differences in sex distribution, age at onset, initial symptoms, motor symptoms, depression, levodopa-equivalent dose, and related complications betweenLRRK2G2385R-carrier andLRRK2G2385R-noncarrier PD patients. Our results suggested that most of the clinical characteristics of PD patients withLRRK2G2385R mutations are similar to those ofLRRK2G2385R noncarriers among Asian PD patients, except for the more common family history, relatively longer disease duration, and higher MMSE scores in the former group.
Keywords
Funding Information
- China Postdoctoral Science Foundation (2016M600638, 81500965, 2017 JM8042)
- National Natural Science Foundation of China (2016M600638, 81500965, 2017 JM8042)
- Natural Science Foundation of Shaanxi Province (2016M600638, 81500965, 2017 JM8042)
This publication has 26 references indexed in Scilit:
- The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean populationParkinsonism & Related Disorders, 2010
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaborationJournal of Clinical Epidemiology, 2009
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control studyThe Lancet Neurology, 2008
- LRRK2 Gly2385Arg mutation and clinical features in a Chinese population with early-onset Parkinson’s disease compared to late-onset patientsJournal of Neural Transmission, 2008
- LRRK2 Gly2385Arg variant is a risk factor of Parkinson’s disease among Han‐Chinese from mainland ChinaEuropean Journal of Neurology, 2008
- The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's diseaseMovement Disorders, 2007
- Comparing LRRK2 Gly2385Arg carriers with noncarriersMovement Disorders, 2007
- Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in AsiaParkinsonism & Related Disorders, 2007
- Leucine-Rich Repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian populationNeuroReport, 2007
- A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson’s disease risk in Taiwanneurogenetics, 2006